This company listing is no longer active
3TP0 Aktienübersicht
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men’s and women’s health.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Acerus Pharmaceuticals Corporation Wettbewerber
Preisentwicklung & Leistung
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.20 |
| 52 Week High | US$7.90 |
| 52 Week Low | US$0.14 |
| Beta | 0.99 |
| 1 Month Change | 0% |
| 3 Month Change | -77.36% |
| 1 Year Change | -95.31% |
| 3 Year Change | -91.05% |
| 5 Year Change | -99.37% |
| Change since IPO | -99.74% |
Aktuelle Nachrichten und Updates
Recent updates
Aktionärsrenditen
| 3TP0 | DE Pharmaceuticals | DE Markt | |
|---|---|---|---|
| 7D | 0% | -0.4% | -2.8% |
| 1Y | -95.3% | -14.6% | 0.5% |
Rendite im Vergleich zur Industrie: 3TP0 underperformed the German Pharmaceuticals industry which returned 3.3% over the past year.
Rendite vs. Markt: 3TP0 underperformed the German Market which returned -2.5% over the past year.
Preisvolatilität
| 3TP0 volatility | |
|---|---|
| 3TP0 Average Weekly Movement | 34.8% |
| Pharmaceuticals Industry Average Movement | 5.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.6% |
Stabiler Aktienkurs: 3TP0's share price has been volatile over the past 3 months.
Volatilität im Zeitverlauf: 3TP0's weekly volatility (35%) has been stable over the past year, but is still higher than 75% of German stocks.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 2008 | 14 | Ed Gudaitis | www.aceruspharma.com |
Acerus Pharmaceuticals Corporation's Grundlagenzusammenfassung
| 3TP0 grundlegende Statistiken | |
|---|---|
| Marktanteil | €2.62m |
| Gewinn(TTM) | -€26.54m |
| Umsatz(TTM) | €2.87m |
0.6x
Kurs-Umsatz-Verhältnis-0.1x
Kurs-Gewinn-VerhältnisIst 3TP0 zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| 3TP0 Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$3.04m |
| Kosten der Einnahmen | US$1.33m |
| Bruttogewinn | US$1.71m |
| Sonstige Ausgaben | US$29.79m |
| Umsatz | -US$28.08m |
Zuletzt gemeldete Gewinne
Sep 30, 2022
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | -3.64 |
| Bruttomarge | 56.32% |
| Nettogewinnspanne | -924.33% |
| Schulden/Eigenkapital-Verhältnis | -329.8% |
Wie hat sich 3TP0 auf lange Sicht entwickelt?
Historische Performance und Vergleiche